Independent Advisor Alliance’s Genenta Science GNTA Stock Holding History

Independent Advisor Alliance’s Portfolio GNTA Stock Details GNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,036	Closed	-$24.9K	–	1284
2026 Q1	$24.9K	Buy	+37,036	New	+$37.5K	﹤0.01%	1584

Other funds holding GNTA

Eurizon Capital SGR SpA Milan $37.3B AUM

Allianz Munich, Germany $9.48B AUM 23.58% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $309M AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $2.96B AUM 25.11% 1-Year Est. Return

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Independent Advisor Alliance's GNTA Position: Q2 2026 in Review

Independent Advisor Alliance sold out of Genenta Science (GNTA) in Q2 2026, closing a stake of 37,036 shares — an estimated $24.9K sold.

Independent Advisor Alliance first reported a position in GNTA in Q1 2026 and held it in 1 quarter. The position peaked at $24.9K in Q1 2026. 9 funds tracked by Wall St. Rank hold GNTA as of Q2 2026.

Independent Advisor Alliance reported no remaining Genenta Science position as of Q2 2026 after selling out during the quarter.
Independent Advisor Alliance sold 37,036 Genenta Science shares in Q2 2026, an estimated $24.9K.
Independent Advisor Alliance first reported a position in Genenta Science in Q1 2026 and held it in 1 quarter.
Independent Advisor Alliance's Genenta Science position peaked at $24.9K in Q1 2026.
9 funds tracked by Wall St. Rank held Genenta Science as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.